Heartland Group Holdings Limited logo

Ongoing Disclosure Notices – Multiple

Insider Disclosure26 March 2021HGHFinancials

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Heartland Group Holdings Limited

Date this disclosure made:

26-Mar-21

Date of last disclosure:

11-Nov-20

Director or senior manager giving disclosure

Full name(s):

Shelley Maree Ruha

Name of listed issuer:

Heartland Group Holdings Limited

Name of related body corporate (if applicable):

Heartland Bank Limited

Position held in listed issuer:

Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary Shares in Heartland Group

Holdings Limited (NZX/ASX: HGH)

Nature of the affected relevant interest(s):

Beneficial Owner

For that relevant interest-

Number held in class before acquisition or disposal:

151,000

Number held in class after acquisition or disposal:

154,116

Current registered holder(s):

Sam Hamana Tiakiwai Ruha

Registered holder(s) once transfers are registered:

Sam Hamana Tiakiwai Ruha

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Not Applicable

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not Applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:16/03/2021

Nature of transaction:

Dividend Reinvestment Plan

Name of any other party or parties to the transaction (if known):Unknown

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:

$5,619.79

Number of financial products to which the transaction related: 3,116

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were aquired or disposed of during a closed period:No

Whether prior written clearance was provided to allow the aquisition or disposal to

proceed during the closed period:

Date of the prior written clearance (if any):

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Cerification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclsoure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:25-Mar-21

Name and title of authorised person:

---

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Heartland Group Holdings Limited

Date this disclosure made:

26-Mar-21

Date of last disclosure:

29-Oct-21

Director or senior manager giving disclosure

Full name(s):

Bruce Robertson Irvine

Name of listed issuer:

Heartland Group Holdings Limited

Name of related body corporate (if applicable):

Heartland Bank Limited

Position held in listed issuer:

Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary Shares in Heartland Group

Holdings Limited (NZX/ASX: HGH)

Nature of the affected relevant interest(s):

(a) Registered Holder and Beneficial

Owner

(b) Beneficial Owner

For that relevant interest-

Number held in class before acquisition or disposal:

(a) 128,591 (b) 445,929

Number held in class after acquisition or disposal:

(a) 131,245 (b) 455,132

Current registered holder(s):

(a) Bruce Robertson Irvine

(b) Mary Therese Irvine

Registered holder(s) once transfers are registered:

(a) Bruce Robertson Irvine

(b) Mary Therese Irvine

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Not Applicable

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not Applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:16/03/2021

Nature of transaction:

Dividend Reinvestment Plan

Name of any other party or parties to the transaction (if known):Unknown

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:

(a) $4,786.56 (b) $16,597.86

Number of financial products to which the transaction related: (a) 2,654 (b) 9,203

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were aquired or disposed of during a closed period:No

Whether prior written clearance was provided to allow the aquisition or disposal to

proceed during the closed period:

N/A (as the acquisition does not

require clearance under Heartland's

financial products trading policy)

Date of the prior written clearance (if any):

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Cerification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclsoure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:25-Mar-21

Name and title of authorised person:

---

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Heartland Group Holdings Limited

Date this disclosure made:

26-Mar-21

Date of last disclosure:

29-Oct-20

Director or senior manager giving disclosure

Full name(s):

Edward John Harvey

Name of listed issuer:

Heartland Group Holdings Limited

Name of related body corporate (if applicable):

Heartland Bank Limited

Position held in listed issuer:

Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary Shares in Heartland Group

Holdings Limited (NZX/ASX: HGH)

Nature of the affected relevant interest(s):

Beneficial Owner

For that relevant interest-

Number held in class before acquisition or disposal:

137,429

Number held in class after acquisition or disposal:

140,265

Current registered holder(s):

Unknown

Registered holder(s) once transfers are registered:

Susan Shirley Harvey

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Not Applicable

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not Applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:16/03/2021

Nature of transaction:

Dividend Reinvestment Plan

Name of any other party or parties to the transaction (if known):Unknown

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:

$5,114.80

Number of financial products to which the transaction related: 2,836

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were aquired or disposed of during a closed period:No

Whether prior written clearance was provided to allow the aquisition or disposal to

proceed during the closed period:

N/A (as the acquisition does not

require clearance under Heartland's

financial products trading policy)

Date of the prior written clearance (if any):

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Cerification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclsoure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:25-Mar-21

Name and title of authorised person:

---

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Heartland Group Holdings Limited

Date this disclosure made:

26-Mar-21

Date of last disclosure:

29-Oct-20

Director or senior manager giving disclosure

Full name(s):

Andrew Peter Dixson

Name of listed issuer:

Heartland Group Holdings Limited

Name of related body corporate (if applicable):

Not Applicable

Position held in listed issuer:

Chief Financial Officer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary shares in Heartland Group

Holdings Limited (NZX/ASX: HGH)

Nature of the affected relevant interest(s):

Registered Holder and Beneficial

Owner

For that relevant interest-

Number held in class before acquisition or disposal:

233,084

Number held in class after acquisition or disposal:

237,895

Current registered holder(s):

Andrew Peter Dixson

Registered holder(s) once transfers are registered:

Andrew Peter Dixson

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Not Applicable

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not Applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:16/03/2021

Nature of transaction: Dividend Reinvestment Plan

Name of any other party or parties to the transaction (if known):Unknown

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:$8,676.77

Number of financial products to which the transaction related: 4,811

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were aquired or disposed of during a closed period:No

Whether prior written clearance was provided to allow the aquisition or disposal to

proceed during the closed period:

N/A (as the acquisition does not

require clearance under Heartland's

financial products trading policy)

Date of the prior written clearance (if any):

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Cerification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclsoure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

25-Mar-21

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

Name and title of authorised person:

---

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Heartland Group Holdings Limited

Date this disclosure made:

26-Mar-21

Date of last disclosure:

29-Oct-20

Director or senior manager giving disclosure

Full name(s):

Michael Jonathan Drumm

Name of listed issuer:

Heartland Group Holdings Limited

Name of related body corporate (if applicable):

Heartland Bank Limited

Position held in listed issuer:

Chief Risk Officer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary shares in Heartland Group

Holdings Limited (NZX/ASX: HGH)

Nature of the affected relevant interest(s):

Registered Holder and Beneficial

Owner

For that relevant interest-

Number held in class before acquisition or disposal:

16,971

Number held in class after acquisition or disposal:

17,321

Current registered holder(s):

Michael Jonathan Drumm

Registered holder(s) once transfers are registered:

Michael Jonathan Drumm

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Not Applicable

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not Applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:16/03/2021

Nature of transaction: Dividend Reinvestment Plan

Name of any other party or parties to the transaction (if known):Unknown

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:$631.23

Number of financial products to which the transaction related: 350

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were aquired or disposed of during a closed period:No

Whether prior written clearance was provided to allow the aquisition or disposal to

proceed during the closed period:

N/A (as the acquisition does not

require clearance under Heartland's

financial products trading policy)

Date of the prior written clearance (if any):

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Cerification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclsoure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

25-Mar-21

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

Name and title of authorised person:

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • MEL — Meridian Energy Limited: Ongoing Disclosure Notice
    2021-04-23

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Meridian Energy Limited Date this disclosure made: 23-Apr-21 Date of last disclosu…”

  • PHL — Promisia Healthcare Limited: D&O Notices (Multiple)
    2021-03-24

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Promisia Healthcare Limited Date this disclosure made: 25-Mar-21 Date of last disc…”

  • THL — Tourism Holdings Limited: Ongoing Disclosure Notices
    2021-04-07

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Tourism Holdings Limited Date this disclosure made: 7 April 2021 Date of last disc…”